Trials / Completed
CompletedNCT04363528
Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU
Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Versailles Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of the study is to determine the incidence of deep vein thromboses at Doppler echo in patients with SARS-Cov-2 pneumopathy upon their entry into ICU and after 7 days of hospitalization in ICU. This is a monocentric interventional study (RIPH 2).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Doppler Echo | 2 doppler echo will be done at patients hospitalized in ICU and with SARS-CoV-2 pneumopathy at 7 days apart |
Timeline
- Start date
- 2020-04-24
- Primary completion
- 2020-12-24
- Completion
- 2021-06-24
- First posted
- 2020-04-27
- Last updated
- 2022-07-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04363528. Inclusion in this directory is not an endorsement.